Fapon is sharing its diagnostic innovation prowess with Medica attendees this week (Nov. 17–20) in Düsseldorf, Germany. Specifically, Fapon is showcasing the ways in which artificial intelligence (AI) technology empowers diagnostic R&D and highlighting its Alzheimer’s disease (AD) blood testing solutions.

Fapon’s “AI-driven + a closed loop of dry and wet experiments” R&D model significantly enhances the efficiency of biomarker discovery and diagnostic solution development, according to the company. Its AD blood testing solution—one of the key outcomes of this model—provides IVD manufacturers with a complete set of raw materials and bulk reagents covering core biomarkers, including p-tau 217, p-tau 181, amyloid beta 40, amyloid beta 42, GFAP, NfL, and APOE4. These materials demonstrate high sensitivity and specificity, as well as excellent correlation with predicate kits and established clinical diagnostic tests, enabling the development of more accurate and reliable AD assays.

Fapon is also capitalizing on Medica’s global reach to showcase its one-stop IVD solutions that include IVD raw materials, reagent services, and open-system instruments. Among these, the chemiluminescence one-stop solution stands out, leveraging high-performance core raw materials, a panel of more than 70 self-developed assays, and the flexible Shine i-Series CLIA analyzers covering low to ultra-high throughput to precisely meet testing needs across various scenarios. Notably, Fapon’s Shine mT8000 Fully Automatic Clinical Chemistry and Immunoassay System delivers complete workflow automation in a compact, space-saving footprint of just 5 m².

Fapon also is displaying its high-performance IVD raw materials, including recombinant quality control and calibrator raw materials for key disease markers (RF, HbA1c, HIV/HIV-P24, HCV, TP, HBV, and ToRCH), animal-origin-free IgG blockers, and LAMP solutions for rapid molecular diagnostics.

Fapon’s products and services currently reach more than 70 countries and regions, with over 2,500 partners worldwide. Fapon is a global life sciences organization whose integrated business structure combines AI-powered discovery, one-stop diagnostic solutions, and novel therapies. Its products and services cover the full spectrum of health management across the entire lifecycle, and accelerate the development of precision medicine.